Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

Alibaba Group (NYSE:BABA; HKG:9988) rally faces AI cloud optimism, cash issues

Alibaba Group (NYSE:BABA; HKG:9988) rally faces AI cloud optimism, cash issues

Alibaba Group Holding Limited is working off two sessions right now. Hong Kong is finished for the day, New York is still trading. Hong Kong shares closed at HK$107.50, up 12.21%, with 282.13 million shares traded, nearly triple the usual volume. The ADR was at $108.75 as of 11:46 a.m. ET, higher by $10.61 from the last close. The jump is big, but the ADR is still 44% from its 52-week high of $192.67.
Apple (NASDAQ:AAPL), Broadcom (NASDAQ:AVGO) $30 billion U.S. chip deal puts $2-per-chip math in focus

Apple (NASDAQ:AAPL), Broadcom (NASDAQ:AVGO) $30 billion U.S. chip deal puts $2-per-chip math in focus

Apple will spend more than $30 billion with Broadcom under a U.S. chip supply deal that gives investors a clearer dollar figure on a supplier relationship that had been hard to size. The contract is expected to produce more than 15 billion U.S.-made chips and support Broadcom’s $1.5 billion expansion in Fort Collins, Colorado, Apple said.
Vera Therapeutics (NASDAQ:VERA) stock up; Trutakna approval shifts attention to Q3 kidney data

Vera Therapeutics (NASDAQ:VERA) stock up; Trutakna approval shifts attention to Q3 kidney data

Vera Therapeutics, Inc. finished up 7.05% at $42.96 on Tuesday after U.S. regulators approved Trutakna. The bigger investor focus was on the size of the bid. With 71.78 million shares outstanding from Google Finance and a $2.83 move on the day, that comes out to roughly $203 million more in equity value added. That’s around a third of Vera’s last reported cash, and not a big reset for a $3.08 billion biotech that’s now swapped FDA risk for launch risk.
Palantir (NASDAQ:PLTR) edges higher after Mexico insurer deal

Palantir (NASDAQ:PLTR) edges higher after Mexico insurer deal

Palantir Technologies Inc. moved up late Tuesday morning as the company said Grupo Nacional Provincial, or GNP Seguros, is its first announced commercial customer in Latin America. The news gave Palantir its first non-U.S. commercial reference on a day tech stocks traded down. Nasdaq was open for a normal session. Nasdaq’s 2026 holiday schedule puts the July Independence Day closure on July 3, with regular hours at 9:30 a.m. to 4 p.m. Eastern.
1 22 23 24 25 26 903